Posted On: 06/14/2014 8:20:48 AM
Post# of 30066
Chris,
This is the reason I am setting and not even trying to guess at the timing. Would take a one day run of 30-40% for me to even consider taking a chance selling and buying back, those easy days are gone!!!
The reason:
The Company remains on track to complete CLIA-grade validation and preparation of the Analytical Performance Package (APP) for LymPro in the first half of 2014. We have begun the implementation of our commercial scientific marketing strategy and that foundation begins with an analytically validated assay. We believe this rigor going forward will lead to the most successful commercial launch in the second half of this year and allow us to achieve our corporate objective of establishing LymPro as the standard Alzheimer’s Blood Test in the industry by nurturing the market through its infancy as we prepare LymPro for FDA submissions - Per Chairman Blog
This is the reason I am setting and not even trying to guess at the timing. Would take a one day run of 30-40% for me to even consider taking a chance selling and buying back, those easy days are gone!!!
The reason:
The Company remains on track to complete CLIA-grade validation and preparation of the Analytical Performance Package (APP) for LymPro in the first half of 2014. We have begun the implementation of our commercial scientific marketing strategy and that foundation begins with an analytically validated assay. We believe this rigor going forward will lead to the most successful commercial launch in the second half of this year and allow us to achieve our corporate objective of establishing LymPro as the standard Alzheimer’s Blood Test in the industry by nurturing the market through its infancy as we prepare LymPro for FDA submissions - Per Chairman Blog
(0)
(0)
